Evidence map›Paper›PMID 37998437›Full record

ArticleHealthcare (Basel, Switzerland)2023

Policies, Guidelines, and Practices Supporting Women's Menstruation, Menstrual Disorders and Menopause at Work: A Critical Global Scoping Review.

Danielle Howe, Sarah Duffy, Michelle O'Shea, Alex Hawkey, Jon Wardle, Sophia Gerontakos, Linda Steele, Emilee Gilbert, Lara Owen, Donna Ciccia and 3 more

Open access · goldAbstract readScoping Review
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Menopause in working life.Scandinavian journal of work, environment & health · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Danielle HoweNICM Health Research Institute, Western Sydney University, Sydney 2145, Australia.ORCID 0000-0003-2986-8287
Sarah DuffySchool of Business, Western Sydney University, Sydney 2751, Australia.ORCID 0000-0003-0295-8135
Michelle O'SheaSchool of Business, Western Sydney University, Sydney 2751, Australia.ORCID 0000-0002-9629-5637
Alex HawkeyTranslational Research Institute (THRI), School of Medicine, Western Sydney University, Sydney 2145, Australia.ORCID 0000-0003-0851-9117
Jon WardleNational Centre for Naturopathic Medicine, Faculty of Health, Southern Cross University, Lismore 2480, Australia.ORCID 0000-0001-8813-3542
Sophia GerontakosNational Centre for Naturopathic Medicine, Faculty of Health, Southern Cross University, Lismore 2480, Australia.ORCID 0000-0003-3423-414X
Linda SteeleLaw Health Justice Research Centre, Faculty of Law, University of Technology Sydney, Sydney 2007, Australia.ORCID 0000-0001-6944-7888
Emilee GilbertSchool of Psychology, Western Sydney University, Sydney 2751, Australia.ORCID 0000-0002-1911-8506
Lara OwenSchool of Modern Languages, University of St Andrews, St. Andrews KY16 9PH, UK.ORCID 0000-0003-2955-8094
Donna CicciaNICM Health Research Institute, Western Sydney University, Sydney 2145, Australia.ORCID 0000-0001-7160-8054
Emma CoxEndometriosis UK, London SE1 1SZ, UK.
Rebecca RedmondNational Centre for Naturopathic Medicine, Faculty of Health, Southern Cross University, Lismore 2480, Australia.ORCID 0000-0002-3633-5465
Mike ArmourNICM Health Research Institute, Western Sydney University, Sydney 2145, Australia.ORCID 0000-0001-7539-9851
Western Sydney University · AUSouthern Cross University · AUTranslational Research Institute · AUEndometriosis · GBUniversity of St Andrews · GBUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Objectives: This paper presents a scoping review of global evidence relating to interventions (i.e., policies, practices, guidelines, and legislation) aimed at supporting women to manage menstruation, menstrual disorders, and menopause at work. (2) Methods: Databases including Medline (Ebsco), CINAHL (Ebsco), Scopus, Web of Science, APA PsychInfo (Ebsco), Humanities International Complete (Ebsco), Academic Search Premier (Ebsco), HeinOnline and OSH Update, and Google Scholar were searched in May 2022. (3) Results: Of 1181 unique articles screened, 66 articles are included. Less half of the articles (42%, 28/66) presented/reviewed an intervention related to women's workplace health. A total of 55 out of the 66 articles are set across 13 countries with the remaining 12 articles described as multi-country studies or reviews. Half of the articles presenting/reviewing an intervention were grey literature, with several undertaken in UK and EU member countries. Interventions focusing on supporting women with menopause at work were the most common (43%, 12/28), followed by menstruation (25%, 7/28) and menstrual disorders (7%, 2/28). Across the reviewed articles, recommendations were categorised as adjustments to the physical work environment, information and training needs, and policy and processes. Few articles explicitly presented or affirmed a design-process and/or evaluation tied to their intervention. In lieu of design-process, this review categorises the rationales driving the development of an intervention as: pronatalist, economic rationalism, gendered occupational health concern, cultural shift towards gender equity objectives, and efforts to reduced shame and stigma. (4) Conclusions: There is a growing body of evidence aimed at understanding women's experiences of managing their menstrual and reproductive health in the workplace and how this impacts their work/career trajectories. However, little research is explicitly concerned with exploring or understanding interventions, including their design or evaluation. Most articles report menopause guidelines and are typically confined to the UK and EU-member countries. Despite the prevalence of menstrual disorders (e.g., endometriosis and polycystic ovarian syndrome (PCOS)) there is limited literature focused on how women might be supported to manage symptoms associated with these conditions at work. Accordingly, future policies should consider how women can be better supported to manage menstruation and menstrual disorders at work and recognise the importance of co-design during policy development and post-intervention evaluation. Further research needs to be undertaken on the impact of workplace policies on both employers and employees.

Indexed as

employer guidelinesmenopausemenstrual disordersmenstruationorganisational policyworkplace

Identifiers

PMID37998437
PMCPMC10671631
OpenAlexW4388633572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.